Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  AbbVie    ABBV

ABBVIE

(ABBV)
  Report  
Real-time Quote. Real-time Cboe BZX - 09/19 01:30:28 pm
71.695 USD   +0.60%
09/17ABBVIE : Form 8.3 - Allergan Plc
DJ
09/16ABBVIE : Form 8.3 - AbbVie Inc
AQ
09/16ABBVIE : Form of prospectus reflecting facts events constituting substantive change from last form
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

AbbVie : Form 8.3 -

share with twitter share with LinkedIn share with facebook
share via e-mail
0
09/12/2019 | 10:24am EDT
TIDM0QCV 
 
 
   FORM 8.3 
 
   IRISH TAKEOVER PANEL 
 
   DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, 
TAKEOVER RULES, 2013 
 
   DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 
1% OR MORE 
 
   1. KEY INFORMATION 
 
 
 
 
Name of person dealing (Note 1)                State Street Global Advisors & 
                                               Affiliates 
---------------------------------------------  ------------------------------- 
Company dealt in                               AbbVie Inc. 
---------------------------------------------  ------------------------------- 
Class of relevant security to which            US$0.01 common stock 
 the dealings being disclosed relate (Note 2) 
---------------------------------------------  ------------------------------- 
Date of dealing                                11(th) September 2019 
---------------------------------------------  ------------------------------- 
 
 
 
   2. INTERESTS AND SHORT POSITIONS 
 
   (a) Interests and short positions (following dealing) in the class of 
relevant security dealt in (Note 3) 
 
 
 
 
                                               Long             Short 
-------------------------------------  --------------------  ----------- 
                                         Number      (%)     Number  (%) 
-------------------------------------  ----------  --------  ------  --- 
(1) Relevant securities                68,998,055  4.66590% 
-------------------------------------  ----------  --------  ------  --- 
(2) Derivatives (other than options)          N/A 
-------------------------------------  ----------  --------  ------  --- 
(3) Options and agreements to 
 purchase/sell                                N/A 
-------------------------------------  ----------  --------  ------  --- 
Total                                  68,998,055  4.66590% 
-------------------------------------  ----------  --------  ------  --- 
 
 
   (b) Interests and short positions in relevant securities of the company, 
other than the class dealt in (Note 3) 
 
 
 
 
Class of relevant security:                     Long         Short 
-------------------------------------------  -----------  ----------- 
                                             Number  (%)  Number  (%) 
-------------------------------------------  ------  ---  ------  --- 
(1) Relevant securities                       N/A 
-------------------------------------------  ------  ---  ------  --- 
(2) Derivatives (other than options)          N/A 
-------------------------------------------  ------  ---  ------  --- 
(3) Options and agreements to purchase/sell   N/A 
-------------------------------------------  ------  ---  ------  --- 
Total                                         N/A 
-------------------------------------------  ------  ---  ------  --- 
 
 
   3. DEALINGS (Note 4) 
 
   (a) Purchases and sales 
 
 
 
 
Purchase/sale   Number of relevant securities  Price per unit (Note 5) 
--------------  -----------------------------  ----------------------- 
   Purchase                            50,000                    69.49 
--------------  -----------------------------  ----------------------- 
   Purchase                               400                    69.49 
--------------  -----------------------------  ----------------------- 
   Purchase                               100                    69.58 
--------------  -----------------------------  ----------------------- 
   Purchase                             1,600                    69.49 
--------------  -----------------------------  ----------------------- 
   Purchase                             4,900                    69.49 
--------------  -----------------------------  ----------------------- 
   Purchase                               173                    68.94 
--------------  -----------------------------  ----------------------- 
   Purchase                            16,815                    69.49 
--------------  -----------------------------  ----------------------- 
   Purchase                           368,466                    69.49 
--------------  -----------------------------  ----------------------- 
   Purchase                               342                    69.49 
--------------  -----------------------------  ----------------------- 
   Purchase                               882                    69.49 
--------------  -----------------------------  ----------------------- 
   Purchase                             1,000                    69.49 
--------------  -----------------------------  ----------------------- 
   Purchase                             5,306                    69.49 
--------------  -----------------------------  ----------------------- 
   Purchase                               612                    69.49 
--------------  -----------------------------  ----------------------- 
   Purchase                             3,422                    69.49 
--------------  -----------------------------  ----------------------- 
   Purchase                                39                    69.49 
--------------  -----------------------------  ----------------------- 
   Purchase                               558                    69.49 
--------------  -----------------------------  ----------------------- 
     Sale                                 400                    69.49 
--------------  -----------------------------  ----------------------- 
     Sale                                 200                    69.49 
--------------  -----------------------------  ----------------------- 
     Sale                               1,116                    69.49 
--------------  -----------------------------  ----------------------- 
 
 
   (b) Derivatives transactions (other than options transactions) 
 
 
 
 
Product name,  Nature of transaction  Number of relevant securities  Price per unit 
 e.g. CFD       (Note 6)               (Note 7)                       (Note 5) 
-------------  ---------------------  -----------------------------  -------------- 
N/A 
-------------  ---------------------  -----------------------------  -------------- 
 
 
   (c) Options transactions in respect of existing relevant securities 
 
   (i) Writing, selling, purchasing or varying 
 
 
 
 
Product name,      Writing, selling,  Number of             Exercise  Type, e.g.      Expiry  Option money 
 e.g. call option   purchasing         securities to which   price     American,       date    paid/received 
                    varying etc.       the option relates              European etc.           per unit (Note 5) 
                                       (Note 7) 
-----------------  -----------------  --------------------  --------  --------------  ------  ------------------ 
N/A 
-----------------  -----------------  --------------------  --------  --------------  ------  ------------------ 
 
 
   (ii) Exercising 
 
 
 
 
Product name,      Number of securities  Exercise price per 
 e.g. call option                           unit (Note 5) 
-----------------  --------------------  ------------------ 
N/A 
-----------------  --------------------  ------------------ 
 
 
   (d) Other dealings (including transactions in respect of new securities) 
(Note 4) 
 
 
 
 
Nature of transaction  Details       Price per unit 
 (Note 8)                        (if applicable) (Note 5) 
---------------------  -------  ------------------------- 
N/A 
---------------------  -------  ------------------------- 
 
 
   4. OTHER INFORMATION 
 
   Agreements, arrangements or understandings relating to options or 
derivatives 
 
 
 
 
Full details of any agreement, arrangement or understanding 
 between the person disclosing and any other person 
 relating to the voting rights of any relevant securities 
 under any option referred to on this form or relating 
 to the voting rights or future acquisition or disposal 
 of any relevant securities to which any derivative 
 referred to on this form is referenced. If none, this 
 should be stated. 
----------------------------------------------------------- 
N/A 
----------------------------------------------------------- 
 
 
 
 
 
 
Is a Supplemental Form 8 attached? (Note 9)                       NO 
-------------------------------------------------------  --------------------- 
Date of disclosure                                       12(th) September 2019 
-------------------------------------------------------  --------------------- 
Contact name                                                  Chetan Shah 
-------------------------------------------------------  --------------------- 
Telephone number                                                  020 33956564 
-------------------------------------------------------  --------------------- 
If a connected EFM, name of offeree/offeror with which   N/A 
 connected 
-------------------------------------------------------  --------------------- 
If a connected EFM, state nature of connection (Note     N/A 
 10) 
-------------------------------------------------------  --------------------- 
 
 
 
 
 
 

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ABBVIE
09/17ABBVIE : Form 8.3 - Allergan Plc
DJ
09/16ABBVIE : Form 8.3 - AbbVie Inc
AQ
09/16ABBVIE INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form ..
AQ
09/16ABBVIE : Form of prospectus reflecting facts events constituting substantive cha..
PU
09/16ABBVIE : Report of unscheduled material events or corporate event
PU
09/16ABBVIE INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
09/16A Plan to Fight Hep C -- WSJ
DJ
09/12ABBVIE : Form 8.3 -
DJ
09/12ABBVIE : Form 8.3 -
AQ
09/11UPDATE : Form 8.3 - AbbVie Inc (Correction of Doc)
AQ
More news